REQUEST A DEMO
Total
USD $0.00
Search more companies

Shijiazhuang Yiling Pharmaceutical Co.,Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Shijiazhuang Yiling Pharmaceutical Co.,Ltd Profile Updated: November 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Shijiazhuang Yiling Pharmaceutical Co., Ltd is a stock limited company that was established on August 28, 2001, in Shijiazhuang. It is recognized as a national innovative enterprise and one of the top 50 pharmaceutical companies in China. The company focuses on the research, production, and sales of traditional Chinese medicine. It is also a high-tech enterprise in China. Shijiazhuang Yiling Pharmaceutical Co., Ltd has production lines for capsules, tablets, granules, and injections that have been certified by Good Manufacturing Practice (GMP). Additionally, its chemical drug formulation workshop has obtained certification from the European Union. The company has a strong research and development capability and has undertaken several national and provincial major projects, including the "973" and "863" programs, as well as national science and technology projects in the field of biomedicine. Shijiazhuang Yiling Pharmaceutical Co., Ltd has received more than 20 scientific and technological awards and holds 29 domestic invention patents, 2 international invention patents, and 17 design patents. The company's Chinese medicine production line, certified by the national GMP, and its chemical drug formulation workshop, certified by the European Union, ensure a stable supply in the market.

Headquarters
No. 238, Tianshan Street, High-tech Industrial Development Zone, Shijiazhuang City, Hebei Province
Shijiazhuang; Hebei; Postal Code: 050035

Contact Details: Purchase the Shijiazhuang Yiling Pharmaceutical Co.,Ltd report to view the information.

Website: http://www.yiling.cn

Basic Information
Total Employees:
Purchase the Shijiazhuang Yiling Pharmaceutical Co.,Ltd report to view the information.
Outstanding Shares:
Purchase the Shijiazhuang Yiling Pharmaceutical Co.,Ltd report to view the information.
Registered Capital:
Purchase the Shijiazhuang Yiling Pharmaceutical Co.,Ltd report to view the information.
Financial Auditors:
Purchase the Shijiazhuang Yiling Pharmaceutical Co.,Ltd report to view the information.
Incorporation Date:
December 23, 1996
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
31.53%
Purchase this report to view the information.
20.81%
Purchase this report to view the information.
2.34%
Purchase this report to view the information.
1.89%
Purchase this report to view the information.
1.42%
Subsidiaries
Anguo Dazetang Chinese Herbal Medicine Co., Ltd
100%
Beijing Yiling Biological Engineering Technology Co., Ltd.
100%
Beijing Yiling Business Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Shijiazhuang Yiling Pharmaceutical Co.,Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-25.76%
Total operating revenue
-25.69%
Operating profit (EBIT)
-66.97%
Net Profit (Loss) for the Period
-68.69%
Total assets
-4.71%
Total equity
-3.06%
Operating Profit Margin (ROS)
-13.78%
Net Profit Margin
-11.82%
Return on Equity (ROE)
-10.02%
Debt to Equity Ratio
-2.48%
Quick Ratio
0.08%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?